Live Ventures Incorporated (LIVE)

Live Ventures Incorporated (NASDAQ:LIVE ) Q3 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants David Verret - Chief Financial Officer Greg Powell - Director of Investor Relations Jon Isaac - Chairman, President, CEO Conference Call Participants Joseph Kowalsky - Unidentified Company Operator Good day, everyone, and welcome to the Live Ventures Fiscal Year Q3 2025 Conference Call. [Operator Instructions] Now I'd like to turn the call over to Greg Powell, Director of Investor Relations.

LAS VEGAS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (Nasdaq: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, today announced financial results for its fiscal third quarter 2025 ended June 30, 2025.

LAS VEGAS, July 31, 2025 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (NASDAQ: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, will issue its financial results for its fiscal third quarter ended June 30, 2025, before the market opens on Thursday, August 7, 2025. The Company will hold a conference call to discuss the results on Thursday, August 7, 2025, at 2:00 p.m. Pacific Daylight Time (5:00 p.m. Eastern Daylight Time).

Vancouver, British Columbia--(Newsfile Corp. - July 4, 2025) - Live Energy Minerals Corp. (CSE: LIVE) (OTC Pink: GTREF) ("LIVE" or the "Company") is pleased to announce that further to its news release dated April 10, 2025, the option agreement dated April 9, 2025 (the "Option Agreement") with an arm's length purchaser (the "Purchaser"), has now closed. On June 27, 2025, the Purchaser issued to the Company, 5,500,000 common shares (the "Consideration Shares") and it must pay $50,000 in cash within three (3) years of the effective date of the Option Agreement in order to acquire a 100% undivided interest in two mineral claims totaling approximately 5,355 hectares located in the Province of Saskatchewan (the "Property").

SOUTH SAN FRANCISCO, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that Timothy Lu, M.D.

BOSTON and LONDON, May 22, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced that Abizer Gaslightwala, President and CEO of Akari, will present and discuss recent corporate events at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar on Thursday, May 29, 2025 at 2:00 PM ET.

Live Ventures Incorporated (NASDAQ:LIVE ) Q2 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Jon Isaac - President, Chief Executive Officer, Director David Verret - Chief Financial Officer Greg Powell - Director of Investor Relations Conference Call Participants Joseph Kowalsky - JD Investments Operator Good day, everyone. And welcome to the Live Ventures Fiscal YearSecond Quarter 2025 Conference Call.

LAS VEGAS, May 08, 2025 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (Nasdaq: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, today announced financial results for its fiscal second quarter 2025 ended March 31, 2025.  Fiscal Second Quarter 2025 Key Highlights: Revenue was $107.0 million, compared to $118.6 million in the prior year period Operating income increased $2.9 million to $2.1 million, compared to an operating loss of $0.8 million in the prior year period Successfully negotiated a $19 million reduction on the balance owed under the Flooring Liquidators, Inc. (“Flooring Liquidators”) seller note, which, when including the cancellation of accrued interest and other items, resulted in a $22.8 million net gain for Live Ventures Income before provision for income taxes was $21.1 million, compared to the prior year period loss before benefit from income taxes of $4.5 million.

LAS VEGAS, May 01, 2025 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (NASDAQ: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, will issue its financial results for its fiscal second quarter ended March 31, 2025, before the market opens on Thursday, May 8, 2025. The Company will hold a conference call to discuss the results on Thursday, May 8, 2025, at 2:00 p.m. Pacific Standard Time (5:00 p.m. Eastern Standard Time).

Vancouver, British Columbia--(Newsfile Corp. - April 10, 2025) - Live Energy Minerals Corp. (CSE: LIVE) (OTC Pink: GTREF) ("LIVE" or the "Company") is pleased to announce that it has entered into an option agreement dated April 9, 2025 (the "Option Agreement") with an arm's length purchaser (the "Purchaser"), pursuant to which the Company has granted the Purchaser the exclusive option to acquire a 100% undivided interest in two mineral claims totaling approximately 5,355 hectares located in the Province of Saskatchewan (the "Property"). Pursuant to the Option Agreement, the Company has granted the Purchaser the exclusive right to acquire a 100% interest in the Property (the "Option").

LAS VEGAS, March 28, 2025 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (Nasdaq: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, today announced that Jon Isaac, its President and Chief Executive Officer, acquired 55,796 shares of the Company's common stock in open market transactions valued at approximately $385,000.

Live Ventures Incorporated (NASDAQ:LIVE ) Q1 2025 Earnings Conference Call February 5, 2025 5:00 PM ET Company Participants Greg Powell - Director, IR David Verret - CFO Conference Call Participants Joseph Kowalsky - JD Investments Operator Welcome to the Live Ventures FY 2025 First Quarter Earnings Conference Call. [Operator Instructions] I would now like to turn the call over to Greg Powell, Director of Investor Relations.

LAS VEGAS, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (Nasdaq: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, today announced financial results for its fiscal first quarter 2025 ended December 31, 2024.

LAS VEGAS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (NASDAQ: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, will issue its financial results for its fiscal first quarter ended December 31, 2024, before the market opens on Thursday, February 6, 2025. The Company will hold a conference call to discuss the results on Thursday, February 6, 2025, at 2:00 p.m. Pacific Standard Time (5:00 p.m. Eastern Standard Time).

ISELIN, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) earlier this year for the first authorized use of an ophthalmic formulation of bevacizumab for the treatment of wet age-related macular degeneration (wet AMD), today announced that Lawrence A.

Live webcast on Wednesday, January 29 th at 2:40 PM ET PRINCETON, NJ, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced that  Pankaj Mohan, Ph.D., Chief Executive Officer of Sonnet will present at LIVE!